Kobayashi Pharmaceutical Co., Ltd.

32
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3301100008
JPY
5,693.00
84 (1.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Kobayashi Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
3,744.00
13,914.00
27,559.00
27,950.00
27,636.00
26,635.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7,744.00
-2,612.00
-6,579.00
6,403.00
-1,950.00
220.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
25,590.00
11,246.00
18,360.00
31,914.00
22,419.00
23,986.00
Cash Flow from Investing Activities
-154.00
-18,415.00
-19,576.00
-14,312.00
7,991.00
-12,656.00
Cash Flow from Financing Activities
-7,921.00
-7,768.00
-19,463.00
-20,759.00
-10,377.00
-6,019.00
Net Cash Inflow / Outflow
18,719.00
-13,717.00
-19,789.00
-2,484.00
20,830.00
4,886.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,204.00
1,220.00
890.00
673.00
797.00
-425.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kobayashi Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
3744
217.66936695849
3,527.00
1620.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
7744
-9.20176624168544
7,753.00
84257.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
25590
302.337422978618
25,288.00
8364.05%
Cash Flow from Investing Activities
-154
-200.195603959043
46.00
23.08%
Cash Flow from Financing Activities
-7921
-80.262719655824
-7,841.00
-9768.84%
Net Cash Inflow / Outflow
18719
33.6488003705578
18,686.00
55530.51%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1204
11.769701006807
1,193.00
10129.66%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 127.55% vs -38.75% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
25,590.00
11,246.00
127.55%